The American public now has access to the Epstein files, after the Department of Justice released files associated with late ...

After more than 30 years since she was first diagnosed with a myeloproliferative neoplasm, Nona Baker is hopeful for the future thanks to current clinical trial landscape. After more than 30 years ...

President Trump made a sudden 180 on releasing the Epstein files in recent days, now encouraging House Republicans to release them all. But the hosts of “The View” aren’t buying it; for them, it’s ...

There are a number of variables affecting PV project performance, which need to be quantified with high-quality data. Image: Solargis. As solar energy transitions ...

Scientists in China have developed a novel missingness-aware power forecasting method that leverages signal decomposition, multi-scale covariate interaction, and multi-domain collaborative transfer ...

TOLEDO, Ohio (WTVG) - FilmToledo will be hosting a special free viewing party for the first two episodes of a new comedy series from the creators of The Office. The Paper is set in Toledo and follows ...

Want to know why your high-value pages aren’t getting indexed? Or why Google keeps crawling useless parameters over and over and over…but not your blog? Your server logs hold the answers. Yes, they’re ...

Forbes contributors publish independent expert analyses and insights. Davey Winder is a veteran cybersecurity writer, hacker and analyst. Update, July 30, 2025: This story, originally published on ...

"The View" co-host Sunny Hostin has appeared to change her tone on releasing files related to deceased sex trafficker Jeffrey Epstein amid outrage over the Trump administration's declaration that ...

Surbhi Sidana, MD, MBBS, director of the Myeloma Disease Focused Group at Stanford University, provides a reintroduction to CARTITUDE-4 and insight on how this phase 3 investigation builds on previous ...

Rusfertide significantly reduced phlebotomy needs in PV patients, with 76.9% achieving clinical response versus 32.9% in the placebo group. The therapy maintained hematocrit levels below 45% in 62.6% ...